Should I buy Edgewell Personal Care (EPC) stock or is it too late?
⭐ The most reliable of them, either direction: UBS — 58% of its targets hit on this sector (48 calls tested). It aims for $32 (+12 %), call made on August 7, 2026, maturing on August 7, 2027 (21 d ago).
Firm-by-firm track record on Edgewell Personal Care
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Morgan Stanley | 80 % | +9.6 % | 5 | $21 -27% |
| Barclays | 70 % | +3.4 % | 10 | $29 +1% |
| RBC Capital | 20 % | -8.8 % | 5 | $35 +22% |
| Wells Fargo | 36 % | -10.8 % | 11 | $30 +5% |
| Canaccord Genuity | 14 % | -12.5 % | 7 | $34 +19% |
| Citigroup | 18 % | -18.0 % | 11 | $50 +74% |
✅ Reasons to believe
- 60% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
- Median price target $32, i.e. +12% from the current price ($29).
⚠️ Reasons to hesitate
- Even the most reliable firm on EPC, Morgan Stanley (80% hit rate, 5 scored calls), only targets $21 (call made on November 18, 2025, maturing on November 18, 2026) (-27%) in its most recent call. The stock may already have run past its target.
- The consensus is not unanimous: of 5 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on EPC
Median target $32 (+12%) · 5 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Edgewell Personal Care now?
We won't decide for you. The facts: 60% of analysts rate it a buy, median target $32 (+12%), and Morgan Stanley (most reliable on EPC, 80%) targets $21. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Edgewell Personal Care?
Not according to analysts: the median target ($32) is still +12% above the current price ($29) (most reliable on EPC: Morgan Stanley, 80%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Edgewell Personal Care still worth investing in?
It depends on the gap between the price ($29) and its estimated value: analysts target $32 on median (+12%), with 60% buys (most reliable on EPC: Morgan Stanley, 80%). Cross-check with their real reliability on EPC and the cautions above. Information, not advice.
What's the main risk in buying EPC?
Even the most reliable firm on EPC, Morgan Stanley (80% hit rate, 5 scored calls), only targets $21 (call made on November 18, 2025, maturing on November 18, 2026) (-27%) in its most recent call. The stock may already have run past its target.
→ Go deeper: the full Edgewell Personal Care profile (consensus, analyst reliability, price target, performance).